Ong JP - Search Results

1

Correlation between ammonia levels and the severity of hepatic encephalopathy.

Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, Arroliga AC, Mullen KD. Ong JP, et al. Am J Med. 2003 Feb 15;114(3):188-93. doi: 10.1016/s0002-9343(02)01477-8. Am J Med. 2003. PMID: 12637132 Clinical Trial.

2

Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.

Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Aggarwal A, et al. Among authors: ong jp. Chest. 2001 May;119(5):1489-97. doi: 10.1378/chest.119.5.1489. Chest. 2001. PMID: 11348958 Clinical Trial.

3

Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy.

Shen B, Younossi ZM, Dolmatch B, Newman JS, Henderson JM, Ong JP, Gramlich T, Yamani M. Shen B, et al. Among authors: ong jp. Am J Med. 2001 Jun 1;110(8):657-60. doi: 10.1016/s0002-9343(01)00701-x. Am J Med. 2001. PMID: 11382375 No abstract available.

4

The utility of radiological imaging in nonalcoholic fatty liver disease.

Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. Saadeh S, et al. Among authors: ong jp. Gastroenterology. 2002 Sep;123(3):745-50. doi: 10.1053/gast.2002.35354. Gastroenterology. 2002. PMID: 12198701

5

Challenges of designing hepatic encephalopathy treatment trials.

Sanaka MR, Ong JP, Mullen KD. Sanaka MR, et al. Among authors: ong jp. Hepatology. 2003 Aug;38(2):527-8. doi: 10.1002/hep.510380231. Hepatology. 2003. PMID: 12903650 No abstract available.

6

Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit.

Aggarwal A, Ong JP, Goormastic M, Nelson DR, Arroliga AC, Farquhar L, Mayes J, Younossi ZM. Aggarwal A, et al. Among authors: ong jp. Transplant Proc. 2003 Dec;35(8):2998-3002. doi: 10.1016/j.transproceed.2003.10.005. Transplant Proc. 2003. PMID: 14697960

7

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O'Shea R, Carey WD, Ferguson R. Younossi ZM, et al. Among authors: ong jp. J Clin Gastroenterol. 2004 Sep;38(8):705-9. doi: 10.1097/01.mcg.0000135372.10846.2a. J Clin Gastroenterol. 2004. PMID: 15319656

8

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.

Younossi ZM, McCullough AC, Barnes DS, Post A, Ong JP, O'Shea R, Martin LM, Bringman D, Farmer D, Levinthal G, Mullen KD, Carey WD, Tavill AS, Ferguson R, Gramlich T. Younossi ZM, et al. Among authors: ong jp. Dig Dis Sci. 2005 May;50(5):970-5. doi: 10.1007/s10620-005-2673-y. Dig Dis Sci. 2005. PMID: 15906777 Clinical Trial.

9

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.

Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, Boparai N. Ong J, et al. Liver Transpl. 2001 Sep;7(9):797-801. doi: 10.1053/jlts.2001.24644. Liver Transpl. 2001. PMID: 11552214 Free article.

10

Outcome of de novo hepatitis C virus infection in heart transplant recipients.

Ong JP, Barnes DS, Younossi ZM, Gramlich T, Yen-Lieberman B, Goormastic M, Sheffield C, Hoercher K, Starling R, Young J, Smedira N, McCarthy P. Ong JP, et al. Hepatology. 1999 Nov;30(5):1293-8. doi: 10.1002/hep.510300519. Hepatology. 1999. PMID: 10534352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters